MarketPulse

lung cancer

2 articles
BenzingaBenzinga··Vandana Singh

J&J Wins FDA Clearance for Accelerated Monthly Dosing of Lung Cancer Therapy

J&J's lung cancer therapy Rybrevant Faspro gains FDA approval for accelerated monthly dosing, maintaining efficacy while improving patient convenience and reducing treatment burden.
JNJFDA approvalRybrevant Faspro
BenzingaBenzinga··Vandana Singh

Eli Lilly's Retevmo Shows Significant Benefit in Early-Stage Lung Cancer Trial

Eli Lilly's Retevmo shows significant benefits in early-stage lung cancer, reducing recurrence risk in Phase 3 trial. Positive results may expand the drug's use beyond advanced-stage disease.
LLYclinical triallung cancer